TIMELINE-More trouble for Valeant as possible debt default looms
March 15 (Reuters) - Valeant Pharmaceuticals International Inc , which has been under scrutiny over its pricing and accounting practices, cut its 2016 sales and earnings forecast on Monday, and said...
No comments:
Post a Comment